stoxline Quote Chart Rank Option Currency Glossary
  
Covetrus, Inc. (CVET)
20.99  0 (0%)    10-12 16:00
Open: 20.93
High: 21
Volume: 5,300,387
  
Pre. Close: 20.99
Low: 20.93
Market Cap: 0(M)
Technical analysis
2022-11-18 4:19:44 PM
Short term     
Mid term     
Targets 6-month :  24.52 1-year :  28.64
Resists First :  21 Second :  24.52
Pivot price 20.98
Supports First :  20.95 Second :  20.93
MAs MA(5) :  20.98 MA(20) :  20.98
MA(100) :  20.86 MA(250) :  19.02
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  85.7 D(3) :  85.7
RSI RSI(14): 68.7
52-week High :  21.2 Low :  13.39
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ CVET ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 21.02 - 21.12 21.12 - 21.21
Low: 20.68 - 20.8 20.8 - 20.9
Close: 20.81 - 21 21 - 21.16
Company Description

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.

Headline News

Tue, 06 Sep 2022
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBT - Markets Insider

Mon, 13 Jun 2022
Deal Diary: Debevoise, Ropes Aid CD&R, TPG in Covetrus Buyout - The Deal Pipeline

Wed, 25 May 2022
Covetrus to Be Taken Private for $4 Billion - Barron's

Wed, 25 May 2022
Covetrus to Be Acquired by CD&R and TPG | Clayton Dubilier & Rice, LLC - Clayton Dubilier & Rice, LLC

Wed, 25 May 2022
Covetrus to Be Acquired by Clayton, Dubilier & Rice and TPG at an Enterprise Valuation of Approximately $4 Billion - Business Wire

Thu, 13 Jan 2022
Is Covetrus (NASDAQ:CVET) A Risky Investment? - Nasdaq

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Distribution
Shares Out 138 (M)
Shares Float 105 (M)
Held by Insiders 0.6 (%)
Held by Institutions 95.8 (%)
Shares Short 4,860 (K)
Shares Short P.Month 2,820 (K)
Stock Financials
EPS -0.22
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 11.3
Profit Margin -0.9 %
Operating Margin -0.3 %
Return on Assets (ttm) -0.2 %
Return on Equity (ttm) -2.6 %
Qtrly Rev. Growth 4.1 %
Gross Profit (p.s.) 6.22
Sales Per Share 33.53
EBITDA (p.s.) 1.14
Qtrly Earnings Growth 0 %
Operating Cash Flow 126 (M)
Levered Free Cash Flow 131 (M)
Stock Valuations
PE Ratio -95.41
PEG Ratio 1.6
Price to Book value 1.85
Price to Sales 0.62
Price to Cash Flow 22.95
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android